Advertisement
Advances in Pediatrics

Adrenal Tumors in Childhood

      Adrenocortical tumors are rare in children and usually present with virilization before age 5 years. They may also present as Cushing syndrome or with mixed effects.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Pediatrics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ishimoto H.
        • Jaffe R.B.
        Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit.
        Endocr Rev. 2011; 32: 317-355
        • Imai A.
        • Kurihara Y.
        Endogenous infection in mice with streptozotocin-induced diabetes. A feature of bacterial translocation.
        Can J Microbiol. 1984; 30: 1344-1348
        • Ogle J.W.
        Unusually large mass of carcinomatous deposit in one of the suprarenal capsules of a child.
        Trans Pathol Soc Lond. 1865; 16: 250
        • Faria A.M.
        • Almeida M.Q.
        Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults.
        Mol Cell Endocrinol. 2012; 351: 52-57
        • Brondani V.B.
        • Fragoso M.
        Pediatric adrenocortical tumor - review and management update.
        Curr Opin Endocrinol Diabetes Obes. 2020; 27: 177-186
        • Garritano S.
        • Gemignani F.
        • Palmero E.I.
        • et al.
        Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect.
        Hum Mutat. 2010; 31: 143-150
        • Michalkiewicz E.
        • Sandrini R.
        • Figueiredo B.
        • et al.
        Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry.
        J Clin Oncol. 2004; 22: 838-845
        • Gupta N.
        • Rivera M.
        • Novotny P.
        • et al.
        Adrenocortical carcinoma in children: a clinicopathological analysis of 41 patients at the Mayo Clinic from 1950 to 2017.
        Horm Res Paediatr. 2018; 90: 8-18
        • Ilias I.
        • Sahdev A.
        • Reznek R.H.
        • et al.
        The optimal imaging of adrenal tumours: a comparison of different methods.
        Endocr Relat Cancer. 2007; 14: 587-599
        • Ribeiro R.C.
        • Pinto E.M.
        • Zambetti G.P.
        • et al.
        The international pediatric adrenocortical tumor registry initiative: contributions to clinical, biological, and treatment advances in pediatric adrenocortical tumors.
        Mol Cell Endocrinol. 2012; 351: 37-43
        • Li F.P.
        • Fraumeni Jr., J.F.
        Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?.
        Ann Intern Med. 1969; 71: 747-752
        • Gonzalez K.D.
        • Noltner K.A.
        • Buzin C.H.
        • et al.
        Beyond Li Fraumeni syndrome: clinical characteristics of families with p53 germline mutations.
        J Clin Oncol. 2009; 27: 1250-1256
        • Varley J.M.
        • McGown G.
        • Thorncroft M.
        • et al.
        Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors.
        Am J Hum Genet. 1999; 65: 995-1006
        • Latronico A.C.
        • Pinto E.M.
        • Domenice S.
        • et al.
        An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors.
        J Clin Endocrinol Metab. 2001; 86: 4970-4973
        • Ribeiro R.C.
        • Sandrini F.
        • Figueiredo B.
        • et al.
        An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.
        Proc Natl Acad Sci U S A. 2001; 98: 9330-9335
        • Gaujoux S.
        • Pinson S.
        • Gimenez-Roqueplo A.P.
        • et al.
        Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.
        Clin Cancer Res. 2010; 16: 5133-5141
        • Rattis F.M.
        • Voermans C.
        • Reya T.
        Wnt signaling in the stem cell niche.
        Curr Opin Hematol. 2004; 11: 88-94
        • Tissier F.
        • Cavard C.
        • Groussin L.
        • et al.
        Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
        Cancer Res. 2005; 65: 7622-7627
        • Rauschecker M.
        • Stratakis C.A.
        Molecular genetics of adrenocortical tumor formation and potential pharmacologic targets.
        Minerva Endocrinol. 2012; 37: 133-139
        • Lapunzina P.
        Risk of tumorigenesis in overgrowth syndromes: a comprehensive review.
        Am J Med Genet C Semin Med Genet. 2005; 137C: 53-71
        • Peixoto Lira R.C.
        • Fedatto P.F.
        • Marco Antonio D.S.
        • et al.
        IGF2 and IGF1R in pediatric adrenocortical tumors: roles in metastasis and steroidogenesis.
        Endocr Relat Cancer. 2016; 23: 481-493
        • Doghman M.
        • El Wakil A.
        • Cardinaud B.
        • et al.
        Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors.
        Cancer Res. 2010; 70: 4666-4675
        • Pinto E.M.
        • Chen X.
        • Easton J.
        • et al.
        Genomic landscape of paediatric adrenocortical tumours.
        Nat Commun. 2015; 6: 6302
        • De Martino M.C.
        • van Koetsveld P.M.
        • Feelders R.A.
        • et al.
        IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer.
        Endocrine. 2019; 64: 673-684
        • Weiss L.M.
        Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors.
        Am J Surg Pathol. 1984; 8: 163-169
        • Mendonca B.B.
        • Lucon A.M.
        • Menezes C.A.
        • et al.
        Clinical, hormonal and pathological findings in a comparative study of adrenocortical neoplasms in childhood and adulthood.
        J Urol. 1995; 154: 2004-2009
        • Wieneke J.A.
        • Thompson L.D.
        • Heffess C.S.
        Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients.
        Am J Surg Pathol. 2003; 27: 867-881
        • Chatterjee G.
        • DasGupta S.
        • Mukherjee G.
        • et al.
        Usefulness of Wieneke criteria in assessing morphologic characteristics of adrenocortical tumors in children.
        Pediatr Surg Int. 2015; 31: 563-571
        • Rodriguez-Galindo C.
        • Figueiredo B.C.
        • Zambetti G.P.
        • et al.
        Biology, clinical characteristics, and management of adrenocortical tumors in children.
        Pediatr Blood Cancer. 2005; 45: 265-273
        • Sullivan M.
        • Boileau M.
        • Hodges C.V.
        Adrenal cortical carcinoma.
        J Urol. 1978; 120: 660-665
        • Sandrini R.
        • Ribeiro R.C.
        • DeLacerda L.
        Childhood adrenocortical tumors.
        J Clin Endocrinol Metab. 1997; 82: 2027-2031
        • Mihai R.
        Diagnosis, treatment and outcome of adrenocortical cancer.
        Br J Surg. 2015; 102: 291-306
        • Reibetanz J.
        • Jurowich C.
        • Erdogan I.
        • et al.
        Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma.
        Ann Surg. 2012; 255: 363-369
        • Ho J.
        • Turkbey B.
        • Edgerly M.
        • et al.
        Role of radiotherapy in adrenocortical carcinoma.
        Cancer J. 2013; 19: 288-294
        • Redlich A.
        • Boxberger N.
        • Strugala D.
        • et al.
        Systemic treatment of adrenocortical carcinoma in children: data from the German GPOH-MET 97 trial.
        Klin Padiatr. 2012; 224: 366-371
        • Chortis V.
        • Taylor A.E.
        • Schneider P.
        • et al.
        Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5alpha-reductase, explaining the need for personalized glucocorticoid and androgen replacement.
        J Clin Endocrinol Metab. 2013; 98: 161-171
        • Pinto E.M.
        • Zambetti G.P.
        • Rodriguez-Galindo C.
        Pediatric adrenocortical tumours.
        Best Pract Res Clin Endocrinol Metab. 2020; 34: 101448
        • Lodish M.
        • Stratakis C.A.
        A genetic and molecular update on adrenocortical causes of Cushing syndrome.
        Nat Rev Endocrinol. 2016; 12: 255-262
        • Almeida M.Q.
        • Stratakis C.A.
        Carney complex and other conditions associated with micronodular adrenal hyperplasias.
        Best Pract Res Clin Endocrinol Metab. 2010; 24: 907-914
        • Gunther D.F.
        • Bourdeau I.
        • Matyakhina L.
        • et al.
        Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity?.
        J Clin Endocrinol Metab. 2004; 89: 3173-3182
        • Bertherat J.
        • Horvath A.
        • Groussin L.
        • et al.
        Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes.
        J Clin Endocrinol Metab. 2009; 94: 2085-2091
        • Kamilaris C.D.C.
        • Faucz F.R.
        • Voutetakis A.
        • et al.
        Carney complex.
        Exp Clin Endocrinol Diabetes. 2019; 127: 156-164
        • Louiset E.
        • Stratakis C.A.
        • Perraudin V.
        • et al.
        The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.
        J Clin Endocrinol Metab. 2009; 94: 2406-2413
        • Lowe K.M.
        • Young Jr., W.F.
        • Lyssikatos C.
        • et al.
        Cushing syndrome in carney complex: clinical, pathologic, and molecular genetic findings in the 17 affected Mayo Clinic patients.
        Am J Surg Pathol. 2017; 41: 171-181
        • Bourdeau I.
        • Parisien-La Salle S.
        • Lacroix A.
        Adrenocortical hyperplasia: a multifaceted disease.
        Best Pract Res Clin Endocrinol Metab. 2020; 34: 101386
        • Lodish M.
        Genetics of adrenocortical development and tumors.
        Endocrinol Metab Clin North Am. 2017; 46: 419-433
        • Carney J.A.
        • Young W.F.
        • Stratakis C.A.
        Primary bimorphic adrenocortical disease: cause of hypercortisolism in McCune-Albright syndrome.
        Am J Surg Pathol. 2011; 35: 1311-1326
        • Vassiliadi D.A.
        • Tsagarakis S.
        Diagnosis and management of primary bilateral macronodular adrenal hyperplasia.
        Endocr Relat Cancer. 2019; 26: R567-R581
        • Stratakis C.A.
        • Berthon A.
        Molecular mechanisms of ARMC5 mutations in adrenal pathophysiology.
        Curr Opin Endocr Metab Res. 2019; 8: 104-111
        • Berends A.M.A.
        • Buitenwerf E.
        • de Krijger R.R.
        • et al.
        Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: a nationwide study and systematic review.
        Eur J Intern Med. 2018; 51: 68-73
        • de Tersant M.
        • Genere L.
        • Freycon C.
        • et al.
        Pheochromocytoma and Paraganglioma in children and adolescents: experience of the French Society of Pediatric Oncology (SFCE).
        J Endocr Soc. 2020; 4: bvaa039
        • Virgone C.
        • Andreetta M.
        • Avanzini S.
        • et al.
        Pheochromocytomas and paragangliomas in children: data from the Italian Cooperative Study (TREP).
        Pediatr Blood Cancer. 2020; 67: e28332
        • Wyszynska T.
        • Cichocka E.
        • Wieteska-Klimczak A.
        • et al.
        A single pediatric center experience with 1025 children with hypertension.
        Acta Paediatr. 1992; 81: 244-246
        • Bausch B.
        • Wellner U.
        • Bausch D.
        • et al.
        Long-term prognosis of patients with pediatric pheochromocytoma.
        Endocr Relat Cancer. 2014; 21: 17-25
        • Lenders J.W.
        • Duh Q.Y.
        • Eisenhofer G.
        • et al.
        Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.
        J Clin Endocrinol Metab. 2014; 99: 1915-1942
        • Rao D.
        • Peitzsch M.
        • Prejbisz A.
        • et al.
        Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
        Eur J Endocrinol. 2017; 177: 103-113
        • Lenders J.W.M.
        • Kerstens M.N.
        • Amar L.
        • et al.
        Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension.
        J Hypertens. 2020; 38: 1443-1456
        • Nolting S.
        • Ullrich M.
        • Pietzsch J.
        • et al.
        Current management of pheochromocytoma/paraganglioma: a guide for the practicing clinician in the era of precision medicine.
        Cancers (Basel). 2019; 11: 1505
        • Lenders J.W.
        • Willemsen J.J.
        • Eisenhofer G.
        • et al.
        Is supine rest necessary before blood sampling for plasma metanephrines?.
        Clin Chem. 2007; 53: 352-354
        • Pacak K.
        • Eisenhofer G.
        • Tischler A.S.
        Phaeochromocytoma - advances through science, collaboration and spreading the word.
        Nat Rev Endocrinol. 2020; 16: 621-622
        • Han S.
        • Suh C.H.
        • Woo S.
        • et al.
        Performance of (68)Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET in detection of pheochromocytoma and paraganglioma: a systematic review and metaanalysis.
        J Nucl Med. 2019; 60: 369-376
        • Ilanchezhian M.
        • Jha A.
        • Pacak K.
        • et al.
        Emerging treatments for advanced/metastatic pheochromocytoma and paraganglioma.
        Curr Treat Options Oncol. 2020; 21: 85
        • Jochmanova I.
        • Pacak K.
        Genomic landscape of pheochromocytoma and paraganglioma.
        Trends Cancer. 2018; 4: 6-9
        • Grubbs E.G.
        • Rich T.A.
        • Ng C.
        • et al.
        Long-term outcomes of surgical treatment for hereditary pheochromocytoma.
        J Am Coll Surg. 2013; 216: 280-289
        • Mercado-Asis L.B.
        • Wolf K.I.
        • Jochmanova I.
        • et al.
        Pheochromocytoma: a genetic and diagnostic update.
        Endocr Pract. 2018; 24: 78-90